Talonvest Structures $21.6M in CMBS Loans for two Colorado Properties
16 janv. 2025 14h12 HE
|
Talonvest Capital, Inc.
NEWPORT BEACH, Calif., Jan. 16, 2025 (GLOBE NEWSWIRE) -- Talonvest Capital, Inc. is proud to announce two recent closings for Guardian Storage. The first was a $13,200,000 non-recourse permanent...
Western Metallica Announces Bridge Financing
16 janv. 2025 08h45 HE
|
Western Metallica Resources Corp.
TORONTO, Jan. 16, 2025 (GLOBE NEWSWIRE) -- Western Metallica Resources Corp. (TSXV: WMS) (“Western Metallica” or the “Company”) announces it has secured bridge financing in the amount of...
Radical Catheter Technologies’ 8F Neurovascular Catheter Receives US FDA 510(k) Clearance, Second for the Best-in-Class Ribbon Technology Platform
15 janv. 2025 09h00 HE
|
Radical Catheter Technologies
CAMPBELL, Calif., Jan. 15, 2025 (GLOBE NEWSWIRE) -- Radical™ Catheter Technologies, a pioneering medical device company focused on advancing the next generation of endovascular access and delivery,...
GoldHaven Announces Non-Brokered Private Placement
14 janv. 2025 09h00 HE
|
GoldHaven Resources Corp.
GoldHaven announces non-brokered private placement of up to 8,000,000 units (the "Offering") at $0.25 per unit for gross proceeds of up to $2,000,000.
E8, Inc. Announces Collaborative Partnership with Jacobs Institute to Make Minimally Invasive Solutions the Gold Standard in Neurosurgery
14 janv. 2025 08h00 HE
|
E8, Inc.
LOS GATOS, Calif., Jan. 14, 2025 (GLOBE NEWSWIRE) -- E8, Inc. unveiled its next-generation suite of tools designed to turn the promise of minimally invasive neurosurgical access devices, including...
Numab Therapeutics Announces Series C Extension to CHF 180 Million, Completing Oversubscribed CHF 50 Million Financing
09 janv. 2025 10h00 HE
|
Numab Therapeutics AG
CHF 50 Million extension round co-led by Cormorant Asset Management, with participation from other existing investors Proceeds will be used to support the advancement of multiple first-in-class and...
Angelini Ventures co-leads €20 million Series A financing in Neumirna Therapeutics to Develop Next-Generation RNA Therapeutics for Epilepsy and other Neurological Disorders
08 janv. 2025 02h00 HE
|
Angelini Ventures
Angelini Ventures co-leads alongside Invivo Partners with participation from Innovestor’s Life Science Fund and other existing investors Financing will support clinical development of Neumirna‘s...
Kintavar conclut une entente définitive pour la vente de la Pourvoirie Fer à Cheval
02 janv. 2025 07h00 HE
|
Kintavar Exploration inc.
MONTRÉAL, 02 janv. 2025 (GLOBE NEWSWIRE) -- Exploration Kintavar Inc. (la « Société » ou « Kintavar ») (TSX-V : KTR), est heureuse d'annoncer qu'à la suite de son communiqué de presse du 30...
Kintavar enters Definitive Agreement to Sell the Fer à Cheval Outfitter
02 janv. 2025 07h00 HE
|
Kintavar Explorations Inc.
MONTREAL, Jan. 02, 2025 (GLOBE NEWSWIRE) -- Kintavar Exploration Inc. (the “Corporation” or “Kintavar”) (TSX-V: KTR), is pleased to announce that further to its December 30, 2024 press release, it...
Harfang complète un financement accréditif
30 déc. 2024 07h00 HE
|
Harfang Exploration inc.
MONTRÉAL, 30 déc. 2024 (GLOBE NEWSWIRE) -- Harfang Exploration Inc. (« Harfang » ou la « Société ») (TSX.V : HAR) est heureuse d’annoncer la clôture d’un placement privé sans courtier (le...